Back to Search
Start Over
His quest: A drug for Ebola.
- Source :
- Crain's Chicago Business; 9/22/2014, Vol. 37 Issue 38, p0004-0004, 1p
- Publication Year :
- 2014
-
Abstract
- The article features 75-year-old cancer researcher Eliezer Huberman and his company Novadrug LLC, which develops drugs against deadly viruses like Ebola, Marburg and hepatitis C as of September 2014. It claims that the company's compound drugs against Ebola and Marburg were tested to be effective at the U.S. Army Medical Research Institute of Infectious Diseases in Maryland. It presents a brief personal and professional profile of Huberman, including his training as geneticist in Israel.
Details
- Language :
- English
- ISSN :
- 01496956
- Volume :
- 37
- Issue :
- 38
- Database :
- Supplemental Index
- Journal :
- Crain's Chicago Business
- Publication Type :
- Periodical
- Accession number :
- 98547708